Clinical Trial Update: Malaysia Stop Tyrosine Kinase Inhibitor Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update from Malaysia regarding a Tyrosine Kinase Inhibitor for leukemia, chronic myeloid leukemia; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Snippet

Sponsor: Ministry of Health, Malaysia | Conditions: Leukemia, Chronic Myeloid | Phase 3 | Status: UNKNOWN